Twist Bioscience
A proprietary semiconductor-based synthetic DNA manufacturing process featuring a 10,000-well silicon platform capable of producing synthetic biology tools, such as oligonucleotides, genes, pathways, chassis and genomes.
Royalty Pharma
Acquisition of royalty interests in marketed and late stage biopharmaceutical products.
QuantaLife
Next generation PCR technology that quantifies DNA molecules by Droplet Digital™ PCR.